Metabolon

Metabolon is the industry-leading metabolomics service provider, with over 25 years of experience and a proprietary platform analyzing over 5,400 metabolites. It serves as a key partner for researchers and drug developers, generating high-impact data that has been cited in thousands of publications. The company operates on a B2B services model, providing end-to-end solutions from data generation to bioinformatics and expert interpretation, primarily within the diagnostics and research tools sector.

Proprietary metabolomics platform combining UHPLC/MS/MS analytical chemistry with the world's largest curated biochemical reference library (over 5,400 Level 1 annotated metabolites) and an integrated bioinformatics software suite for data analysis and multiomics integration.

Metabolon competes with large contract research organizations (CROs) offering omics services, specialized metabolomics startups, and academic core facilities. Its primary competitive advantage is its 25-year head start, resulting in the industry's largest proprietary metabolite library and a vast repository of methodological expertise and published data.